Alpha-1-acid glycoprotein (AGP-1) is a major positive acute phase glycoprotein with unknown functions that likely plays a role in inflammation. We tested its involvement in a variety of inflammatory responses using human AGP-1 purified to apparent homogeneity and confirmed its identity by immunoblotting and mass spectrometry. AGP-1 alone upregulated MAPK signaling in murine peritoneal macrophages.
Introduction
Sepsis is a dysregulated inflammatory disorder that follows infection and is a major leading cause of mortality globally in the intensive care units (ICU) (Singer, et al., 2016 , Chaudhry and Duggal, 2014 , Phua, et al., 2013 . Bacterial endotoxins such as the lipopolysaccharide (LPS) or membrane lipoproteins such as Braun lipoprotein (BLP) have often been used to mimic sepsis in in vivo models (Lakshmikanth, et al., 2016 , Remick, et al., 2000 , Jacob, et al., 2016 , Lakshmikanth, et al., 2016 . Sepsis involves a complex interplay of proinflammatory and anti-inflammatory actions in response to multiple mediators (Frost, et al., 2002 , Lu, et al., 2008 . LPS and BLP are detected by the pattern recognition receptors (PRRs), TLR-4 and TLR-2, respectively (Lakshmikanth, et al., 2016, Maeshima and Fernandez, 2013) , to upregulate myriad of genes that amplify the inflammatory response (Lu, et al., 2008) . The initial hyper-inflammatory response during sepsis is counterregulated by compensatory anti-inflammatory response (CAR) (van der Poll and van Deventer, 1999) .
Endogenous serum factors including acute phase proteins are part of CAR and help in maintaining homeostasis (Johnson, et al., 1999) . Alpha-1-acid glycoprotein (AGP-1) is a major acute phase glycoprotein, whose levels increase several fold during sepsis (Fournier, et al., 2000) . AGP-1, a positive acute phase protein, has an unusually low pI of 2.8 -3.8 and contains glycosyl moieties accounting for up to 45% of its mass (Fournier, et al., 2000 , Schmid, et al., 1980 . Numerous biological activities have been attributed to AGP-1 (Hochepied, et al., 2003) , yet its exact function(s) remain to be delineated. Both elevated (Frazier, 2011) and decreased (Barroso-Sousa, et al., 2013 ) levels of AGP-1 have been reported in sepsis, with correlation to mortality. In isolation, AGP-1 inhibits neutrophil migration to the infection site via nitric oxide, promoting inadequate pathogen clearance (Mestriner, et al., 2007) . On the contrary, increased AGP-1 concentration is reported to limit adverse inflammatory reactions through a negative feedback loop (Libert, et al., 1994, Roitt and Delves, 1998) .
This study determined whether AGP-1 modulates endotoxin-mediated sepsis using isolated cells and an in vivo murine model of sepsis (Lakshmikanth, et al., 2016) . We demonstrate that AGP-1 selectively augments lipoprotein-mediated inflammatory responses suggesting a novel mechanism of action.
containing fractions were pooled and concentrated by spin concentrators (10 kDa cut off) (Agilent Technologies, USA). The concentrate was then applied to a DEAE-cellulose column (25 x 0.5 cm) equilibrated with 30 mM acetate buffer (pH 5.0). Fractions were eluted with buffer containing sodium chloride (0 -2 M) at a flow rate of 24 ml/ hour. AGP-1 containing fractions were pooled, concentrated, and quantified using Lowry's method (Lowry, et al., 1951) . The endotoxin content of purified AGP-1 was assessed by Limulus amebocyte lysate (LAL) assay (Endochrome -K TM , Charles River, SC, USA) as per manufacturer's instructions.
SDS-PAGE and Western blotting for AGP-1
AGP-1 samples were resolved on a reducing SDS-PAGE (7.5 % acrylamide), visualized either by silver staining or PAS staining (Zacharius, 1969) and subjected to Western blotting. Blots were stained using appropriate primary antibody (anti-human AGP-1 monoclonal antibody; 1:10000 v/v) and secondary antibody (anti-mouse IgG HRP conjugate; 1:5000 v/v). The blots were visualized using freshly prepared ECL reagent by UV-transillumination (Uvi-Tech, Cambridge, UK).
Mass spectral analysis of AGP-1
Purified samples were resolved on SDS-PAGE, visualized using Coomassie stain, AGP-1 excised, and the band destained with 30% methanol for 4 hours. Upon reduction (10 mM dithiothreitol) and alkylation (65 mM 2-chloroacetamide) of the cysteines, proteins were digested overnight with sequencing grade modified trypsin. The resulting peptides were resolved on a nano-capillary reverse phase column (Acclaim PepMap C18, 2 micron, 50 cm, Thermo Scientific) using a 1% acetic acid/acetonitrile gradient at 300 nl/min and directly introduced into Q Exactive HF mass spectrometer (Thermo Scientific, San Jose CA). MS1 scans were acquired at 60 K resolution (AGC target=3e6, max IT=50ms). Data-dependent high-energy C-trap dissociation MS/MS spectra were acquired for the 20 most abundant ions (Top20) following each MS1 scan (15 K resolution; AGC target=1e5; relative CE ~28%). Proteome Discoverer (V 2.1; Thermo Scientific) software suite was used to identify the peptides by searching the HCD data against an appropriate database. Search parameters included MS1 mass tolerance of 10 ppm and fragment tolerance of 0.1 Da. False discovery rate (FDR) was determined using Fixed PSM validator and proteins/peptides with a FDR of ≤ 1 % were retained for further analysis.
Purification of Braun lipoprotein (BLP) from E. coli DH5α
Purification of BLP was carried out as before (Lakshmikanth, et al., 2015) . The final precipitate was dissolved in 10 mM sodium phosphate buffer (pH 7.4) containing 1% SDS (S-buffer). The endotoxin content in the purified BLP was assessed by Limulus amebocyte lysate (LAL) assay using Endochrome -KTM kit (Charles River, SC, USA) as per manufacturer's instructions.
Isolation of murine peritoneal macrophages
Mice received an intraperitoneal injection of 3 ml thioglycollate broth (3% w/v). Macrophages were harvested 3 days later by washing peritoneal cavity with ice-cold PBS, and the resulting cells were resuspended in RPMI medium containing 2% FBS. These cells were incubated for 2 hours at 37 o C and 5% CO 2 . Adherent cells were used as peritoneal macrophages.
MAPK signaling
Adherent mouse peritoneal macrophages (2 x 10 6 cells/ml) were stimulated for 30 min with AGP-1 (25, 50, and 100 µg/ml) with or without BLP (100 ng/ml) or LPS (100 ng/ml). Unstimulated macrophages were the negative control. Lysates were prepared using Radio-Immunoprecipitation Assay (RIPA) buffer and immunoblots were developed using specific primary and appropriate secondary antibodies for phospho-p38, phospho-JNK, phospho-ERK, and β -actin (1:1000 v/v).
Murine endotoxemia
Murine endotoxemia was induced by administering the LPS (E. coli O111: B4) or BLP in the presence of the hepatotoxin D-galactosamine (Lakshmikanth, et al., 2016 , Jacob, et al., 2016 . BLP (5, 10, and 15 mg/kg) was administered intraperitoneally in the presence or absence of AGP-1 (25 mg/kg) to Swiss albino mice. LPS was injected intraperitoneally at 15 mg/kg in the presence or absence of AGP-1. Survival and clinical signs were monitored for 24 hours. All animals were euthanized 24 hours post-treatment with LPS or BLP.
Neutrophil Adhesion Assay
Neutrophils were isolated freshly from healthy human volunteer with informed consent. The neutrophils were isolated by dextran sedimentation and separation over ficoll density gradient centrifugation (Watanabe, et al., 2003) . Neutrophil-rich pellet obtained was suspended 1ml of Hank's-Balanced salt solution (HBSS) containing 0.2% human serum albumin (HBSS/A). For assessment of adhesion, neutrophil suspension was loaded with calcein-AM to a final concentration of 1 μ M prior to incubation for a period of 45 min at 37 0 C. The labelled neutrophils were incubated with LPS and BLP (100 ng/ml) with or without AGP-1 (25, 50, and 100 µg/ml) in triplicate wells in twelve well cell culture plates (Nest Biotechnology Co. Ltd., China) pre-coated with 0.2% gelatin. The adherent neutrophils were visualized and photographed at a magnification of 10x under fluorescent microscope (Lakshmikanth, et al., 2016) . The number of cells adhered in each well was determined by counting the cells adhered in 10 randomly chosen fields using ImageJ software and then calculating the average number of cells adhered per filed.
Statistical analysis
The animal experiments are representative of more than 2 independent experiments and the statistical significance among groups was determined by log-rank test. Un-paired two-tailed t-test was used to compare the mean for each treatment group with the mean of the control group. All other results were analyzed using oneway analysis of variance (ANOVA) where applicable.
Results
Purification of AGP-1 from human serum and its identity with commercial AGP-1
Commercial purified human plasma AGP-1 showed batch-to-batch variation in the electrophoretic mobility of its components (data not shown), prompting us to purify AGP-1 in large quantities from healthy human volunteers. AGP-1 purified by conventional chromatographic techniques (Fig 1 A and B) showed apparent homogeneity (Figs 1 C, D and E) as a 43 kDa glycoprotein. Further, LC/MS analyses of the purified tryptic peptides were compared with the commercially available AGP-1 and were found to be identical and mapped to the predicted human sequence. Isolated AGP-1 showed a protein mass of 23.5 kDa with a pI of 5.02
( Fig 1F) . The endotoxin content of the purified AGP-1 was < 7 EU/mg protein.
AGP-1 inhibits LPS but not BLP -induced MAPK activation
Previous studies have emphasized MAPK pathway as a critical component of bacterial endotoxinmediated sepsis (Lu, et al., 2008 , Frazier, et al., 2012 . We examined the effect of AGP-1 on bacterial endotoxins-mediated MAPK activation in mouse peritoneal macrophages. As expected both LPS and BLP were potent activators of MAPK signaling (Fig 2 B and D) . We found AGP-1 alone (25, 50 and 100 µg/ml) activated MAPK signalling and that at the highest concentration that AGP-1 was as effective as LPS in stimulating p38, JNK, and ERK kinase phosphorylation (Fig 2 A and C) . Unexpectedly, the combination of AGP-1 and LPS diminished p38 and JNK phosphorylation induced by LPS (100 ng/ml) stimulation in a concentration-dependent manner. Except at the lowest tested concentration (25 µg/ml) where the combination was more effective than LPS alone. AGP-1 also diminished LPS-induced ERK phosphorylation (Fig 2 B and D) . In contrast, AGP-1 augmented BLP-mediated p38, JNK, and ERK phosphorylation. Thus, despite the similarity of TLR4 and TLR-2 signaling, AGP-1 elicits opposite outcomes in response to LPS or BLP.
AGP-1 selectively augments TLR-2 mediated responses in vivo
LPS induced a time-dependent mortality in 50% of the injected Swiss albino mice from 16 to 24 hours post injection (Fig 3A inset) . The hepatoxin D-galactosamine (D-GalN) alone had no effect on the survival of these mice, but greatly enhanced the susceptibility to 15 mg/kg LPS and shortened the time to death, with 100% lethality by 12 hours in response to the combination of D-GalN and LPS (Fig 3 insets) . AGP-1 had no effect on mortality by itself, but delayed and reduced lethality of the D-GalN/LPS combination (Fig 3 insets) . BLP at 10 or 15 mg/kg did not induce mortality in Swiss albino mice. Addition of D-GalN in combination with the lowest dose of BLP induced mortality over the last hour of the experiment (Fig 3) . However, addition of AGP-1 to the combination of 10 mg/kg BLP and D-GalN advanced the time of lethality to 8 to 9 hours post injection. AGP-1 itself had no effect on viability. A higher dose of BLP in combination with the hepatotoxin proved to enhance the effect and was more lethal than the lower dose of BLP (Fig 3) . Inclusion of AGP-1 enhanced the process where the time to initiation of death was reduced to just 5 hours post-injection (Fig 3) . The time to death of multiple animals was not altered by increasing the amount of LPS or addition of AGP-1 ( 
AGP-1 selectively augments TLR-2 mediated neutrophil adhesion in vitro.
Further, to validated this selective effect of AGP-1 on TLR-2 in humans, we used a primary immune cell, neutrophils as they are the first immune cells to be recruited to the site of inflammation (Kumar and Sharma, 2010) . Neutrophils under normal conditions are free flowing in nature, however, upon inflammation neutrophils adhere to the endothelial layer/extra-cellular matrix via cell adhesion molecules like β 2 integrins, a calcium dependent pathway (Leick, et al., 2014) . This phenomenon was employed to assess the effect of AGP-1 on both TLR-2 and TLR-4 mediated neutrophil adhesion. Labelled neutrophils were stimulated with LPS and BLP with or without AGP-1. AGP-1 alone dose dependently activated neutrophils. However, neutrophils when incubated with AGP-1 in combination with LPS/ BLP, AGP-1, as seen in in vivo, preferentially augmented TLR-2 mediated while inhibited the TLR-4 mediated adhesion of neutrophils (Fig 4) .
Discussion
Sepsis is the leading cause of death globally accounting for 250,000 deaths each year (de Pablo, et al., 2014) . Culturable microbes and/ or their products including the membrane components, LPS and lipoproteins of gram negative bacteria, mimic the pathobiology of sepsis (Lakshmikanth, et al., 2016 , Lakshmikanth, et al., 2016 . Although there are several strategies employed to tackle sepsis, more than 100 clinical trials to control sepsis have failed till date (Lakshmikanth, et al., 2016) . A new approach is to utilize the endogenous serum components such as the acute phase proteins. However, these proteins exhibit both anti-inflammatory (Libert, et al., 1994 , Dalli, et al., 2014 , Sander, et al., 2010 and pro-inflammatory (Ceciliani, et al., 2002) effects. Dalli et.
al. (Dalli, et al., 2014) and Vandevyver et. al. (Vandevyver, et al., 2014) have suggested that the acute phase proteins like alpha-2-macroglobulin (A2MG) can be used as a therapeutic agent against sepsis. With this background in mind, we sought to test the effects of yet another acute phase protein, AGP-1, in murine model of sepsis, although this protein too exhibits both pro-and anti-inflammatory effects (Hochepied, et al., 2003) .
One of the problems that we encountered was the presence of multi-molecular forms of AGP-1 in commercial preparations. While studying each of the molecular forms individually would be ideal, isolating them in adequate amounts for experiments would be an insurmountable task. Hence, in this study, we isolated AGP-1 from pooled healthy human serum to apparent homogeneity using fairly simple and effective purification strategies that exhibited uniformity in its molecular form (Fig 1) .
We used mouse peritoneal macrophages to test the functionality of this protein in modifying endotoxininduced MAPK signaling using LPS and BLP to stimulate TLR-4 and TLR-2 respectively, since both TLRs are 1 0
Interestingly, AGP-1 alone dose-dependently activated the MAP kinases (p38, JNK and ERK) (Fig 2 A and C (Komori, et al., 2012) , the findings in our study suggest mechanistic underpinnings with purified AGP-1 in primary cells rather than an immortalized cell line. Furthermore, we report for the first time the divergent signaling mechanisms of AGP-1 on the modulation of MAP kinases where the acute-phase protein preferentially inhibited LPS-dependent signaling, but not BLP-induced TLR-2 activation of MAPK (Fig 2 B and D) . These results highlight an unexpected diversity of TLR signaling and the complex role(s) of AGP-1 in modifying signaling from PRRs.
Our studies confirm that AGP-1 has a selective effect on murine endotoxemia using models previously established in our laboratory (Lakshmikanth, et al., 2016 , Jacob, et al., 2016 . We found that AGP-1 at a dose of 25 mg/kg body weight neither potentiated nor protected TLR-4 -mediated mortality (Fig 3) . This is in agreement with the previous studies, although surprisingly high doses of both LPS and AGP-1 were used (50 mg/kg and 1 g/kg respectively) (Hochepied, et al., 2003 , Hochepied, et al., 2000 , Moore, et al., 1997 , McCurdy, et al., 2014 . In stark contrast, AGP-1 at the same concentration significantly and selectively potentiated TLR-2-mediated mortality (Fig 3) , confirming the differential role for AGP-1 as seen in MAPK signaling, where AGP-1 inhibits MAPKs induced by TLR-4, which may in turn limit the activation of NF-κB and thereby delays the LPS induced mortality.
In order to check if the murine in vitro data can be translated to humans, human neutrophils were stimulated with LPS and BLP with or without AGP-1. Moreover, previous studies have indicated an antiinflammatory role for AGP-1 as it inhibited the migration of neutrophils. Thus, indicating that AGP-1 does not have a role in neutrophil activation (Mestriner, et al., 2007 , Matsumoto, et al., 2007 , Vasson, et al., 1994 . In our study, AGP-1 not only activated neutrophils dose dependently but was as potent as that of both TLR-2 and TLR-4 agonists (Fig 4) . However, neutrophils when stimulated with LPS and/or BLP in combination with AGP-1, it again showed its preferential augmentation of TLR-2 mediated neutrophil adhesion and inhibited TLR-4 mediated effects. Thus validating the results observed in in vivo murine model of endotoxemia and MAPK signaling in murine macrophages.
In conclusion, we show for the first time that AGP-1 has differential effects on TLR-2 and TLR-4 signaling mechanisms both in in vivo and in vitro that impacts the outcome in terms of survival and lethality in response to specific agonists of these PRRs. The effect of AGP-1 on the TLRs has been summarized in figure 5 . 
